PATENT CLAIM ANALYSIS

Application Number: 15865037
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "186100"]

Abstract:
The present invention provides system and methods for detecting an analyte indicative of an influenza viral infection in a sample of bodily fluid. The present invention also provides for systems and method for detection a plurality of analytes, at least two of which are indicative of an influenza viral infection in a sample of bodily fluid.

Claim (Index 85):
A fluidic device comprising:\n a sample collection unit configured to receive a sample of bodily fluid from a subject suspected to contain an influenza viral particle; an assay assembly in fluidic communication with the sample collection unit, the assay assembly comprising a first reagent chamber, a second reagent chamber, a reaction site, and a fluidic channel that connects the first and second reagent chambers with the reaction site, wherein the first reagent chamber comprises a first immunoassay reagent and the second reagent chamber comprises a second immunoassay reagent; and a waste chamber in fluidic communication with the assay assembly, wherein the assay assembly is configured to:\n receive the sample from the sample collection unit; \n release the first and second immunoassay reagents from the first and second reagent chambers to the reaction site through the fluidic channel by one or more actuating elements; \n allow the sample to react with the first and second immunoassay reagents at the reaction site, wherein the first immunoassay reagent binds to a hemagglutinin molecule to form a first immune complex on the influenza viral particle, and wherein the second immunoassay reagent binds to a neuraminidase molecule to form a second immune complex on the influenza viral particle; \n yield one or more signals indicative of the simultaneous presence of hemagglutinin and neuraminidase on the influenza viral particle based on the first and second immune complexes; and \n detect the influenza viral particle in the sample based on detection of the one or more signals indicative of the simultaneous presence of hemagglutinin and neuraminidase.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 86.0
- Lexical Diversity: 1.73529
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13187960', '11746535', '11389409', '12750518', '14868208']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7582200827905708
- 35 USC 102 Novelty (BERT): 0.5873272977068388
- Combined Prediction Score: 0.7411308042821977
- Mean Citation Score: 377.66397799999993
- Max Citation Score: 544.4576400000002
- Similarity Product: 420.7294575007154

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test